- $1.65bn
- $2.88bn
- $2.47bn
- 56
- 56
- 80
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,218 | 1,905 | 2,906 | 2,706 | 2,470 |
Cost of Revenue | |||||
Gross Profit | 2,193 | 1,882 | 2,883 | 2,677 | 2,443 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,972 | 1,721 | 1,652 | 2,520 | 2,345 |
Operating Profit | 246 | 184 | 1,255 | 186 | 125 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 214 | 146 | 1,221 | 155 | 103 |
Provision for Income Taxes | |||||
Net Income After Taxes | 162 | 109 | 978 | 113 | 62.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 117 | 80.1 | 751 | 83.3 | 42.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 108 | 70.3 | 745 | 110 | 42.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.612 | 0.416 | 3.8 | 0.493 | 0.267 |
Dividends per Share |